| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $9.01M | - | |
| Dir | 135.9K | $5.29M | - | |
| VP | 90.4K | $3.52M | -9,000 | |
| CFO | 36.7K | $1.43M | - | |
| Dir | 35.8K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $28.18 | $281,845.00 | -10.0% | +9.5% | +1.4% | |
| Mar 4, 2022 | Snyderman Nancy Lynn Md | Director | Buy | 427 | $23.43 | $10,004.61 | +4.8% | +28.3% | +17.6% | |
| Feb 23, 2022 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 11,983 | $24.76 | $296,649.95 | -40.0% | +17.5% | +13.4% | |
| Feb 18, 2022 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 2,306 | $25.17 | $58,042.02 | -19.5% | +17.5% | +11.9% | |
| Aug 23, 2021 | Alva Emily Peterson | Director | Buy | 1,650 | $30.22 | $49,860.40 | New | -24.8% | -17.1% | |
| Aug 19, 2021 | Brown Iain Michael | SVP, Chief Financial Officer | Sale+OE | 40,000 | $29.99 | $1,199,600.00 | -48.2% | -22.3% | -15.2% | |
| Aug 2, 2021 | McKeon Brian P69 | Director | Buy | 10,000 | $26.43 | $264,269.00 | New | +11.1% | -4.9% | |
| Jul 29, 2021 | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sale+OE | 14,000 | $26.00 | $364,000.00 | -15.8% | +12.1% | +0.2% | |
| Jul 1, 2021 | Anstice David W | Director | Sale+OE | 20,000 | $24.58 | $491,504.00 | -21.5% | +24.1% | +22.6% | |
| Jun 10, 2021 | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sale+OE | 13,500 | $25.00 | $337,500.00 | -15.3% | +19.2% | +9.2% |